Patent cliff

A sharp decline in revenues experienced by biopharma companies upon patent expiration for leading products due to incoming biosimilar or generic competition.

Source: Life Sciences Mergers and Acquisitions Firepower Report (EY) · p.10

Reports that mention Patent cliff

Life Sciences Snapshot: A Quarterly Report on Financing Trends, Q1 2026Orrick / PitchBook

Have a question about Patent cliff? Ask the AI, answers cite the source.